Hognasbacka, A, Poot, A, Plisson, C, Bergare, J, McCluskey, S, Bonsall, D, Wells, L, Kooijman, E, Schuit, R, Verlaan, M, Beaino, W, van Dongen, G, Vugts, D, Elmore, C, Passchier, J & Windhorst, A 2022, ' Synthesis and preclinical evaluation of [C-11]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor ', Nuclear Medicine and Biology, vol. 108, pp. S38-S39 . Nuclear Medicine and Biology, 108, S38-S39. Elsevier Inc.
Nuclear Medicine and Biology, 96-97, S51-S52. Elsevier Inc. Hognasbacka, A, Kooijman, E, Schuit, R, Schreurs, M, Verlaan, M, Beaino, W, Vugts, D, van Dongen, G, Poot, A & Windhorst, A 2021, ' Synthesis and preclinical evaluation of [methylpiperazine-C-11]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors ', Nuclear Medicine and Biology, vol. 96-97, pp. S51-S52 .